POST Online Media Lite Edition



 

Pfizer to sell infusion business to ICU Medical

Staff Writer |
Pfizer said it would sell its global infusion therapy business to ICU Medical Inc for $1 billion in cash and stock that will give it a major stake in the smaller company.

Article continues below






Pfizer had acquired the hospital infusion system business, which has annual sales of about $1.2 billion, through its $15 billion purchase in September 2015 of Hospira, which sells generic hospital products and is developing biosimilars meant to compete with big-selling biotech drugs.

But Pfizer said in July it was exploring the possible sale of the infusion products to focus on its core pharmaceuticals business.

Pfizer will receive $600 million in cash and nearly $400 million in newly issued shares of ICU Medical, giving it a stake of about 16.6 percent in the company.


What to read next

CVS Caremark to buy Coram from Apria Healthcare
Pfizer thinking about consumer healthcare business sale
Pfizer officially withdraws from AstraZeneca deal